Healthcare provider profile · identity verified

Kyle Schneweis, MD

Family Practice · LIBERTY, MO · NPI 1174834378

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	299	47
Atorvastatin Calcium	Atorvastatin Calcium	296	72
Levothyroxine Sodium	Levothyroxine Sodium	294	41
Lisinopril	Lisinopril	245	58
Amlodipine Besylate	Amlodipine Besylate	219	49
Gabapentin	Gabapentin	207	50
Metformin Hcl	Metformin Hcl	203	40
Tamsulosin Hcl	Tamsulosin Hcl	186	35
Citalopram Hbr	Citalopram Hydrobromide	167	17
Simvastatin	Simvastatin	156	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	137	suppressed
Trazodone Hcl	Trazodone Hcl	136	25
Losartan Potassium	Losartan Potassium	128	36
Duloxetine Hcl	Duloxetine Hcl	116	17
Eliquis	Apixaban	111	15
Baclofen	Baclofen	100	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	90	27
Carvedilol	Carvedilol	87	11
Rosuvastatin Calcium	Rosuvastatin Calcium	83	suppressed
Alendronate Sodium	Alendronate Sodium	80	14
Jardiance	Empagliflozin	78	suppressed
Buspirone Hcl	Buspirone Hcl	77	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	72	23
Albuterol Sulfate Hfa	Albuterol Sulfate	66	21
Lovastatin	Lovastatin	65	suppressed
Famotidine	Famotidine	64	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	64	suppressed
Alprazolam	Alprazolam	62	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	17
Metoprolol Succinate	Metoprolol Succinate	59	16
Meloxicam	Meloxicam	58	17
Metformin Hcl Er	Metformin Hcl	57	suppressed
Risperidone	Risperidone	55	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	54	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	53	suppressed
Januvia	Sitagliptin Phosphate	52	suppressed
Myrbetriq	Mirabegron	50	suppressed
Lactulose	Lactulose	49	suppressed
Colesevelam Hcl	Colesevelam Hcl	48	suppressed
Bupropion Hcl Sr	Bupropion Hcl	47	suppressed
Methylprednisolone	Methylprednisolone	47	40
Fluticasone Propionate	Fluticasone Propionate	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	14
Pravastatin Sodium	Pravastatin Sodium	45	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	39	suppressed
Furosemide	Furosemide	38	11
Naltrexone Hcl	Naltrexone Hcl	37	suppressed
Carbamazepine	Carbamazepine	36	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	36	suppressed
Sertraline Hcl	Sertraline Hcl	35	suppressed
Amoxicillin	Amoxicillin	34	32
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	34	suppressed
Varenicline Tartrate	Varenicline Tartrate	34	suppressed
Linzess	Linaclotide	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	15
Pregabalin	Pregabalin	30	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	29	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Finasteride	Finasteride	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Azithromycin	Azithromycin	26	24
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Synthroid	Levothyroxine Sodium	21	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	20	20
Mupirocin	Mupirocin	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Temazepam	Temazepam	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Diazepam	Diazepam	18	suppressed
Pimozide	Pimozide	18	suppressed
Atenolol	Atenolol	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ozempic	Semaglutide	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Prednisone	Prednisone	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Fenofibrate	Fenofibrate	12	suppressed
Glipizide	Glipizide	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ramipril	Ramipril	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valsartan	Valsartan	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Nystop	Nystatin	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error